article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

2005: HRSA publicly raised alarms against discriminatory reimbursement to 340B providers. There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website.